Single Centre Experience: Bening and Malign Hematological Patients with COVID-19
Introduction Coronavirus disease 2019 (COVID-19) were declared as pandemic by World Health Organization. With this study, we aimed to define our patients who were followed up with malign or benign hematological diagnoses and diagnosed with COVID-19; determine the distribution of this infection in p...
| Main Authors: | , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
TUBITAK
2022-06-01
|
| Series: | Sağlık Akademisi Kastamonu |
| Subjects: | |
| Online Access: | https://dergipark.org.tr/tr/download/article-file/2207465 |
| _version_ | 1797852580060069888 |
|---|---|
| author | Ümit Yavuz Malkan Senem Maral Fatma Yılmaz Merih Reis Aras Buğra Sağlam Mesut Tığlıoğlu Hacer Berna Afacan Öztürk Murat Albayrak Pınar Tığlıoğlu |
| author_facet | Ümit Yavuz Malkan Senem Maral Fatma Yılmaz Merih Reis Aras Buğra Sağlam Mesut Tığlıoğlu Hacer Berna Afacan Öztürk Murat Albayrak Pınar Tığlıoğlu |
| author_sort | Ümit Yavuz Malkan |
| collection | DOAJ |
| description | Introduction
Coronavirus disease 2019 (COVID-19) were declared as pandemic by World Health Organization. With this study, we aimed to define our patients who were followed up with malign or benign hematological diagnoses and diagnosed with COVID-19; determine the distribution of this infection in patient groups and contribute to the literature by creating descriptive statistics with its clinical and demographic features.
Patients and methods:
It is planned to retrospectively examine patients with a history of COVID-19 who were followed up in Hematology Department of Dışkapı Yıldırım Beyazıt Training and Research Hospital with benign and malignant diagnoses.
Results:
88 patients who had COVID-19 infection while being followed in our clinic due to hematological diseases were included in the study. 77 patients had been followed by hematologic malignancies and 11 patients had been followed by benign hematological disease.In the group with malignancy, COVID was found most frequently in patients diagnosed with Philadelphia chromosome negative myeloproliferative neoplasms (22%), nonhodgkin lymphoma (19%) and multiple myeloma (16%). ITP (64%) was the most common disease in patients with benign hematological disorder who had COVID history. 52 (67%) of the malignant cases and 8 (73%) of the bening cases were found to be followed up with the disease in remission.
The all patient's most common symptoms at COVID-19 diagnosis were fever (77%), cough (70%) and weakness (65%). 45% of the patients were isolated at home, 48% were required hospitalization. 49% of patients had mild; 27% had moderate and 24% had severe COVID-19 infection. Almost all of the patients in the moderate and severe disease group were followed up in patients diagnosed with malignant hematological disease. 16 (18%) patients received mechanical ventilation and 16 (18%) patients was transferred intensive care unit. All of the patients who were intubated and needed intensive care were diagnosed with malignant hematological disease. 17 patients died due to COVID-19 infection. The mortality rate was 22% in patients with diagnosis of malignant hematological diseases, and 19% when all patients (malignant and bening) were included.
Conclusion:
In conclusion, the COVID-19 pandemic is a problem all over the world. Determining the course of the disease in certain diagnostic groups is important in the management of both the main disease and the COVID-19 infection. Therefore, the contribution of such recording studies to the literature is important and valuable. |
| first_indexed | 2024-04-09T19:35:35Z |
| format | Article |
| id | doaj.art-64f1fa33e75d4cfebafd3c5791864f38 |
| institution | Directory Open Access Journal |
| issn | 2548-1010 |
| language | English |
| last_indexed | 2024-04-09T19:35:35Z |
| publishDate | 2022-06-01 |
| publisher | TUBITAK |
| record_format | Article |
| series | Sağlık Akademisi Kastamonu |
| spelling | doaj.art-64f1fa33e75d4cfebafd3c5791864f382023-04-04T12:05:59ZengTUBITAKSağlık Akademisi Kastamonu2548-10102022-06-017Covid-19 Ek Sayısı10811510.25279/sak.1061701501Single Centre Experience: Bening and Malign Hematological Patients with COVID-19Ümit Yavuz Malkan0Senem Maral1Fatma Yılmaz2Merih Reis Aras3Buğra Sağlam4Mesut Tığlıoğlu5Hacer Berna Afacan Öztürk6Murat Albayrak7Pınar Tığlıoğlu8Hacettepe Üniversitesi Tıp FakültesiALANYA ALAADDİN KEYKUBAT ÜNİVERSİTESİUNIVERSITY OF HEALTH SCIENCES, ANKARA DIŞKAPI YILDIRIM BEYAZIT HEALTH RESEARCH CENTERUNIVERSITY OF HEALTH SCIENCES, ANKARA DIŞKAPI YILDIRIM BEYAZIT HEALTH RESEARCH CENTERSAĞLIK BİLİMLERİ ÜNİVERSİTESİ, ŞANLIURFA MEHMET AKİF İNAN SAĞLIK UYGULAMA VE ARAŞTIRMA MERKEZİDr. Ersin Arslan Eğitim ve Araştırma Hastanesi,UNIVERSITY OF HEALTH SCIENCES, ANKARA DIŞKAPI YILDIRIM BEYAZIT HEALTH RESEARCH CENTERSAĞLIK BİLİMLERİ ÜNİVERSİTESİ, ANKARA DIŞKAPI YILDIRIM BEYAZIT SAĞLIK UYGULAMA VE ARAŞTIRMA MERKEZİDr. Ersin Arslan Eğitim ve Araştırma HastanesiIntroduction Coronavirus disease 2019 (COVID-19) were declared as pandemic by World Health Organization. With this study, we aimed to define our patients who were followed up with malign or benign hematological diagnoses and diagnosed with COVID-19; determine the distribution of this infection in patient groups and contribute to the literature by creating descriptive statistics with its clinical and demographic features. Patients and methods: It is planned to retrospectively examine patients with a history of COVID-19 who were followed up in Hematology Department of Dışkapı Yıldırım Beyazıt Training and Research Hospital with benign and malignant diagnoses. Results: 88 patients who had COVID-19 infection while being followed in our clinic due to hematological diseases were included in the study. 77 patients had been followed by hematologic malignancies and 11 patients had been followed by benign hematological disease.In the group with malignancy, COVID was found most frequently in patients diagnosed with Philadelphia chromosome negative myeloproliferative neoplasms (22%), nonhodgkin lymphoma (19%) and multiple myeloma (16%). ITP (64%) was the most common disease in patients with benign hematological disorder who had COVID history. 52 (67%) of the malignant cases and 8 (73%) of the bening cases were found to be followed up with the disease in remission. The all patient's most common symptoms at COVID-19 diagnosis were fever (77%), cough (70%) and weakness (65%). 45% of the patients were isolated at home, 48% were required hospitalization. 49% of patients had mild; 27% had moderate and 24% had severe COVID-19 infection. Almost all of the patients in the moderate and severe disease group were followed up in patients diagnosed with malignant hematological disease. 16 (18%) patients received mechanical ventilation and 16 (18%) patients was transferred intensive care unit. All of the patients who were intubated and needed intensive care were diagnosed with malignant hematological disease. 17 patients died due to COVID-19 infection. The mortality rate was 22% in patients with diagnosis of malignant hematological diseases, and 19% when all patients (malignant and bening) were included. Conclusion: In conclusion, the COVID-19 pandemic is a problem all over the world. Determining the course of the disease in certain diagnostic groups is important in the management of both the main disease and the COVID-19 infection. Therefore, the contribution of such recording studies to the literature is important and valuable.https://dergipark.org.tr/tr/download/article-file/2207465coronaviruspandemicsevere acute respiratory syndrome coronavirus 2koronavirüspandemişiddetli akut solunum sendromu koronavirüsü 2 |
| spellingShingle | Ümit Yavuz Malkan Senem Maral Fatma Yılmaz Merih Reis Aras Buğra Sağlam Mesut Tığlıoğlu Hacer Berna Afacan Öztürk Murat Albayrak Pınar Tığlıoğlu Single Centre Experience: Bening and Malign Hematological Patients with COVID-19 Sağlık Akademisi Kastamonu coronavirus pandemic severe acute respiratory syndrome coronavirus 2 koronavirüs pandemi şiddetli akut solunum sendromu koronavirüsü 2 |
| title | Single Centre Experience: Bening and Malign Hematological Patients with COVID-19 |
| title_full | Single Centre Experience: Bening and Malign Hematological Patients with COVID-19 |
| title_fullStr | Single Centre Experience: Bening and Malign Hematological Patients with COVID-19 |
| title_full_unstemmed | Single Centre Experience: Bening and Malign Hematological Patients with COVID-19 |
| title_short | Single Centre Experience: Bening and Malign Hematological Patients with COVID-19 |
| title_sort | single centre experience bening and malign hematological patients with covid 19 |
| topic | coronavirus pandemic severe acute respiratory syndrome coronavirus 2 koronavirüs pandemi şiddetli akut solunum sendromu koronavirüsü 2 |
| url | https://dergipark.org.tr/tr/download/article-file/2207465 |
| work_keys_str_mv | AT umityavuzmalkan singlecentreexperiencebeningandmalignhematologicalpatientswithcovid19 AT senemmaral singlecentreexperiencebeningandmalignhematologicalpatientswithcovid19 AT fatmayılmaz singlecentreexperiencebeningandmalignhematologicalpatientswithcovid19 AT merihreisaras singlecentreexperiencebeningandmalignhematologicalpatientswithcovid19 AT bugrasaglam singlecentreexperiencebeningandmalignhematologicalpatientswithcovid19 AT mesuttıglıoglu singlecentreexperiencebeningandmalignhematologicalpatientswithcovid19 AT hacerbernaafacanozturk singlecentreexperiencebeningandmalignhematologicalpatientswithcovid19 AT muratalbayrak singlecentreexperiencebeningandmalignhematologicalpatientswithcovid19 AT pınartıglıoglu singlecentreexperiencebeningandmalignhematologicalpatientswithcovid19 |